http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4374842-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb75b0b19820e3833ebdcb31603b242b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D267-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D267-14 |
| filingDate | 1981-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1983-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8009b69b33750732f6c6e0924f7d652a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5141e796180b06959d719760a56e88d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_701548b1a7508d08f42aaf90becaa371 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1f53bd76496a2b3bbd1972cef58371b |
| publicationDate | 1983-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-4374842-A |
| titleOfInvention | 4,1-Benzoxazepines and compositions |
| abstract | 4,1-Benzoxazepines of the following formula are central nervous system drugs: <IMAGE> wherein R is hydrogen or C1 to C5 alkyl; X is hydrogen, halogen, or nitro; Y is phenyl, 2-halophenyl, 4-halophenyl, 2-trifluoromethylphenyl, or pyridyl; and <IMAGE> is a group of the formula: <IMAGE> +TR <IMAGE> (wherein Q is oxygen, sulfur, or hydrazono, with a proviso that, when Y is phenyl or 2-halophenyl and R is hydrogen, Q is neither oxygen nor sulfur; R1 is hydrogen, halogen, C1 to C5 alkyl, C1 to C5 alkylthio, 5- or 6-membered heterocycle or C1 to C5 alkyl substituted by a substituent selected from the group consisting of halogen, hydroxy, mercapto, C1 to C5 alkoxy, C1 to C5 alkanoyloxy, C1 to C5 alkylthio, C7 to C9 aralkyldithio, C2 to C10 dialkylamino, C3 to C15 dialkylaminoalkoxy, C3 to C15 dialkylaminoalkylthio, and 5- or 6-membered heterocycle; R2 is C1 to C5 alkyl; and R3 is C1 to C5 alkyl or C3 to C10 dialkylaminoalkyl; with a proviso that when R1 is C1 to C5 alkyl and R is hydrogen, Y is neither phenyl nor 2-halophenyl). |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009215743-A1 |
| priorityDate | 1980-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 457.